Japanese Yen Could Extend Losses on Improved Risk Sentiment, BOJ Remarks
The Japanese yen could fall further on reduced safe-haven flows as risk sentiment recovers and after Bank of Japan’s Uchida said Wednesday […]
‘Top Gun Democrat’ Tim Walz Cultivated Centrist Record in Washington
Representing a rural district, Kamala Harris’s running mate had an ‘A’ rating from the NRA—but also backed abortion rights and same-sex marriage.
Oil Inches Higher Despite Reports of U.S. Stocks Build, China’s Import Data
Oil prices edged higher in volatile trade on reports of a surprise build in U.S. crude inventories and disappointing import data from […]
SoftBank Plans $3.5 Billion Buyback After Surprise Quarterly Loss
The Japanese technology investor reported a surprise first-quarter loss after two consecutive quarters of profits.
Metal Prices Mixed; Gold Flat as Investors Rotate into ETFs
Gold futures were flat and Pepperstone said there are increased flows into gold exchange traded funds and gold buyers supporting the moving […]
Puma Narrows Earnings Targets
Puma narrowed its earnings guidance for the current year, citing muted consumer sentiment, particularly in China, as well as higher freight costs […]
Honda Motor Reports Higher Profit Despite Weak Car Sales in China
The Japanese company maintained its revenue and net profit forecasts for the fiscal year.
Beiersdorf Nivea Demand Offset by China Wekaness
Beiersdorf said its first-half sales and net profit grew, helped by demand for its Nivea skin-care products, though weakness in China hurt […]
Siemens Energy Keeps Guidance as Loss Narrows
Siemens Energy reported a reduced net loss for the third quarter as revenue rose 19%, with its wind unit continuing to recover […]
ABN AMRO Boosts Outlook on Higher Rates
ABN AMRO raised its net interest income guidance for the year as it continued to benefit from higher interest rates, which helped […]
Tesla Recalling Cars in China Over Hood Problem
The carmaker is recalling 1.68 million cars in China to fix the same hood problem that recently affected models in the U.S.
Novo Nordisk Upgrades Sales Forecast on Wegovy Demand
Novo Nordisk raised its full-year sales guidance after revenue from its blockbuster Wegovy obesity treatment surged in the second quarter.